维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：期刊名="Core Evidence"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，12，6：	1
2	An evidence-based review of the potential benefitsof taliglucerase alfa in the treatment of patients with Gaucherdisease显示文摘	Hollak CE	2012	Core Evid2012，7，：	1
3	Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency显示文摘	Kei Nakajima	2012	Core Evidence (default)2012，，：	1
4	Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus显示文摘	Steve Edelman	2010	Core Evidence (default)2010，，：	1
5	Sugammadex as a reversal agent for neuromuscular block: an evidence-based review显示文摘	SCHALLER S J FINK H	2013	Core Evid2013，8，：	1
6	Panitumumab , the evidence of its therapeutic potential in metastatic colorectal cancer care 显示文摘	Martinelli E Morgillo F Troiani T	2007	Core Evid2007，2，2：	1
7	Linaclotide: evidence for its potential use in irritablebowel syndrome and chronic constipation显示文摘	Lee N Wald A	2012	Core Evid2012，7，：	1
8	Ticagrelor : the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Dtez JG	2011	Core Evid2011，6，：	1
9	Rindopepimut an evidence-based re-view of its therapeutic potential in the treatment of EGFRvll I-positive glioblastoma显示文摘	Babu R Adamson DC	2012	Core Evid2012，7，：	1
10	Fosaprepitant and Aprepitant:An update of the evidence for their place in the prevention of chemotherapy - induced nausea and vomiting 显示文摘	Langford P Chrisp P	2010	Core Evidence2010，5，：	1
11	Prucalopride:the evidence for its use in the treatment of chronic constipation显示文摘	Coremans G	2008	Core Evid2008，3，1：	1
12	Ticagrelor:the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，3：	1
13	Exforge (amlodipine/valsartan combination)in hypertension: the evidence of its therapeutic impact显示文摘	Krzesinski JM Cohen EP	2009	Core Evid2009，4，：	1
14	Intravenous zoledronic acid for thetreatment of osteoporosis:The evidence of its therapeuticeffect显示文摘	LEWIECKI E M	2010	Core Evid2010，15，4：	1
15	Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review显示文摘	Mitchell SB Andrew JB Nadine HK	2014	Core Evidence2014，9，20：	1
16	Rindopepimut:an evidence-based re- view of its therapeutic potential in the treatment of EGFRvm- positive glioblastoma显示文摘	Babu R Adamson DC	2012	Core Evid2012，7，：	1
17	An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation显示文摘	Deedwania P Huang GW	2012	Core Evid2012，7，：	1
18	Ticagrelor:the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，3：	1
19	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	LOMBO B DIEZ J G	2011	Core Evid2011，6，1：	1
20	Brodalumab:an evidence-based reviewof its potential in the treatment of moderate-to-severe psoriasis显示文摘	Coimbra S Figueiredo A Santos-Silva A	2014	Core Evid2014，9，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示